First-Ever Delaware Life Science Conference to Convene National and Regional Industry Leaders

FIRST-EVER DELAWARE LIFE SCIENCE CONFERENCE TO CONVENE NATIONAL AND REGIONAL INDUSTRY LEADERS

“Delaware’s DNA” will feature top CEOs, investors, researchers and exciting new companies

ORIGINAL SOURCE: Delaware BioScience Association

NEWARK, DE (February 23, 2023) – An unprecedented collection of life science sector leaders will participate in the inaugural Delaware’s DNA: 2023 Life Science Conference on Thursday, May 11. The event, hosted by the Delaware BioScience Association (Delaware Bio), will convene regional and national biomedical researchers, business leaders, investors and policymakers for a day-long program of rich panel discussions and insightful, expert speakers on the industry’s most critical and timely issues.

Conference headliners include Delaware Governor John Carney, Incyte CEO Hervé Hoppenot, Biotechnology Innovation Organization (BIO) interim CEO Rachel King, Aisling Capital founder Dennis Purcell, National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) Director Kelvin Lee, Prelude Therapeutics CEO Kris Vaddi and Eric Kmiec, Director of the Gene Editing Institute, and founder of CorriXR Therapeutics.

“Delaware’s emerging posture as a global life science leader is clear and exciting,” said Michael Fleming, president of Delaware Bio. “Delaware’s DNA will shine a bright light on the full breadth and diversity of our unique strengths and rapid growth, while exploring the continued focus and investment required to ensure our future impact and success.”

A First-Ever Daylong Life Science Event

The event will showcase Delaware’s thriving life science ecosystem through a full-day program highlighting the momentum and opportunity underlining the state and region’s emergence as a global hub of innovation and growth. This includes:

• An inside perspective on the state of the industry from leading industry analysts and investors
  
• Key issues in economic and workforce development
  
• The regional potential for advanced and biopharmaceutical manufacturing
  
• Advances and innovations in cancer research and treatment
  

Most Promising New Company Competition and Scientific Poster Presentations

Also new this year, Delaware’s DNA will feature exciting new life science businesses vying for the title of “Most Promising New Company.” Companies launched within the last five years are invited to apply to be among those selected to make 5-minute pitches during a full session of conference participants. All event attendees will be eligible to vote on their favorite new companies via a multifunctional app developed for the conference.

Companies selected to participate will receive complimentary access to the conference and gain significant exposure to the most influential industry audience ever assembled in the state. Top vote winners will also be recognized with prizes and invited to share their stories at future Delaware Bio programs.

Another important element of Delaware’s DNA will be poster presentations on cutting-edge science by local researchers. Throughout the conference, students and faculty of area educational and biomedical research institutions will be on hand to share and discuss their compelling work with attendees. A call for proposals for the poster presentations and most promising new company applications will be issued later this week.

Partnering Through the App
The conference app also includes a partnering tool that allows attendees to schedule and conduct one-on-one meetings between companies, researchers, investors and other businesses. Meetings will be hosted on the platform virtually the following Thursday, May 18.

Sponsors
Leading life science enterprises from global companies to research institutes and economic development organizations are partnering with Delaware Bio to make Delaware’s DNA the biggest, most valuable event of its kind in state history. They include:
Avantor, delivered by VWR
ANP Technologies
Biotechnology Innovation Organization (BIO)
Choice MedWaste
Delaware Biotechnology Institute
Delaware Business Times
Delaware Prosperity Partnership
Facility Logix
Incyte
National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)
Prelude Therapeutics
University of Delaware

For conference agenda details, information on sponsorship and to purchase tickets go to: delawarebio.org/page/delawares-dna

Conference Details

Date: Thursday, May 11th

Time: 9:00 am–6:00 pm

Location: The Waterfall, 3416 Philadelphia Pike, Claymont, DE 19703

About Delaware BioScience Association

The Delaware BioScience Association (Delaware Bio) is a catalyst for bioscience innovation in Delaware. We serve pharmaceutical and biotechnology firms, medical device manufacturers, agricultural biotech and chemical companies, research and testing companies, hospitals and medical institutions, academic partners and other organizations and companies that support them, with the goal of expanding our state’s vibrant science economy. Our more than 160 member companies and organizations are of every size, from global leaders to small start-ups, representing 11,000 innovation-based jobs vital to Delaware’s economic future.

Contact
Jamie Pedrick – Director, Marketing and Communications
Jamie.pedrick@delawarebio.org
410-920-2668